Optimizerx Corp(OPRX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Optimizerx Corp

260 CHARLES STREET SUITE 302
WALTHAM MA 02453 USA
P: 248-651-6568
http://www.optimizerx.com

Sectors & Indices

Sector
Industry
Employees

Profile

OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan.

Key Executives

NameTitle
Information not available.

More from The Globe

Two top TSX gainers this year that insiders love (and one big loser)
Ted Dixon
number cruncher
Seven airline stocks that could take flight as oil prices fall
For Number Cruncher column in Globe Investor/ROB only.
Bullish on Gibson Energy Inc.
Monica Rizk
Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
The S&P TSX composite index screen at the TMX Market Centre in downtown Toronto is photographed on Nov. 11, 2022.
Friday’s analyst upgrades and downgrades
Rock bolting on a scissor lift at Wesdome's Kiena Mine in Val d'Or, Quèbec.
Will a new pipeline reinvigorate Canadian energy stocks?
Pumpjacks pump crude oil near Halkirk, Alta., on June 20, 2007. THE CANADIAN PRESS/Larry MacDougal
number cruncher
Nine profitable global semiconductor companies
For Number Cruncher column in Globe Investor/ROB only.
Bullish on Ford Motor Co.
Monica Rizk

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.